Long-Acting Injectable Antiretroviral Therapy Demonstrates Efficacy in HIV Patients with Adherence Challenges: A Critical Analysis

A randomized controlled trial of cabotegravir plus rilpivirine demonstrates non-inferior virologic suppression compared to daily oral therapy in HIV patients with documented adherence difficulties. The findings support expanded use of long-acting injectable regimens in select populations.